The Effect of MGCD0103 on CYP450 Isoforms Activity of Rats by Cocktail Method

MGCD0103, an isotype-selective histone deacetylase inhibitor (HDACi), has been clinically evaluated for the treatment of hematologic malignancies and advanced solid tumors, alone and in combination with standard-of-care agents. In order to investigate the effects of MGCD0103 on the metabolic capacit...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Jinzhang, Zhang, Qingwei, Lin, Kezhi, Hu, Lufeng, Zheng, Yuancai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556830/
https://www.ncbi.nlm.nih.gov/pubmed/26357656
http://dx.doi.org/10.1155/2015/517295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556830/
https://www.ncbi.nlm.nih.gov/pubmed/26357656
http://dx.doi.org/10.1155/2015/517295

Ejemplares similares